PL365380A1 - Skórny układ aplikacyjny dla kwasu aminolewulinowego - Google Patents

Skórny układ aplikacyjny dla kwasu aminolewulinowego

Info

Publication number
PL365380A1
PL365380A1 PL01365380A PL36538001A PL365380A1 PL 365380 A1 PL365380 A1 PL 365380A1 PL 01365380 A PL01365380 A PL 01365380A PL 36538001 A PL36538001 A PL 36538001A PL 365380 A1 PL365380 A1 PL 365380A1
Authority
PL
Poland
Prior art keywords
application system
aminolevulinic acid
dermal application
dermal
aminolaevulinic
Prior art date
Application number
PL01365380A
Other languages
English (en)
Other versions
PL221283B1 (pl
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Original Assignee
Photonamic Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co.Kg filed Critical Photonamic Gmbh & Co.Kg
Publication of PL365380A1 publication Critical patent/PL365380A1/pl
Publication of PL221283B1 publication Critical patent/PL221283B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL365380A 2000-07-17 2001-07-13 Skórny układ aplikacyjny jako samoprzylepny układ matrycowy dla kwasu aminolewulinowego oraz sposób wytwarzania takiego układu i jego zastosowanie PL221283B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034673A DE10034673C1 (de) 2000-07-17 2000-07-17 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
PCT/EP2001/008131 WO2002005809A1 (de) 2000-07-17 2001-07-13 Dermales applikationssystem für aminolävulinsäure

Publications (2)

Publication Number Publication Date
PL365380A1 true PL365380A1 (pl) 2005-01-10
PL221283B1 PL221283B1 (pl) 2016-03-31

Family

ID=7649181

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365380A PL221283B1 (pl) 2000-07-17 2001-07-13 Skórny układ aplikacyjny jako samoprzylepny układ matrycowy dla kwasu aminolewulinowego oraz sposób wytwarzania takiego układu i jego zastosowanie

Country Status (19)

Country Link
US (1) US7951395B2 (pl)
EP (1) EP1303267B1 (pl)
JP (1) JP4469131B2 (pl)
AT (1) ATE263557T1 (pl)
AU (2) AU2001281980B2 (pl)
CA (1) CA2416147C (pl)
CZ (1) CZ299086B6 (pl)
DE (2) DE10034673C1 (pl)
DK (1) DK1303267T3 (pl)
ES (1) ES2215924T3 (pl)
HU (1) HU230272B1 (pl)
NO (1) NO330303B1 (pl)
NZ (1) NZ523798A (pl)
PL (1) PL221283B1 (pl)
PT (1) PT1303267E (pl)
RU (1) RU2262930C2 (pl)
TR (1) TR200400865T4 (pl)
WO (1) WO2002005809A1 (pl)
ZA (1) ZA200210267B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
MX2007013623A (es) * 2005-04-28 2008-02-12 Cosmo Oil Co Ltd Preparacion externa para la piel.
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
RU2379026C2 (ru) * 2008-04-15 2010-01-20 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Композиция для флуоресцентной диагностики и фотодинамической терапии
DE102011111865A1 (de) 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
EP4183328A1 (en) 2017-04-04 2023-05-24 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US10916448B2 (en) 2018-07-05 2021-02-09 Texas Instruments Incorporated Method for creating a wettable surface for improved reliability in QFN packages
US11131796B2 (en) 2018-09-10 2021-09-28 Texas Instruments Incorporated Optical display with spatial light modulator
US12039726B2 (en) 2019-05-20 2024-07-16 Aranz Healthcare Limited Automated or partially automated anatomical surface assessment methods, devices and systems

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (pl) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
PL308116A1 (en) 1992-09-21 1995-07-24 Quadra Logic Technologies Percutaneous in vivo activation of a photosensitive factor present in blood
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
MX9504023A (es) * 1994-09-20 1997-05-31 Johnson & Johnson Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
JPH11514986A (ja) 1995-09-21 1999-12-21 ノバルティス アクチエンゲゼルシャフト 光力学的療法におけるナノ粒子
RU2123326C1 (ru) * 1996-07-18 1998-12-20 Научно-исследовательский институт гематологии и трансфузиологии Фармацевтическая композиция с фотосенсибилизатором
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
RU2151596C1 (ru) * 1999-03-10 2000-06-27 Казанский государственный университет им. В.И. Ульянова-Ленина Композиция аминокислот с микроэлементами и кальцием, обладающая противоопухолевой, антидепрессивной и противоаритмической активностью
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
AU2002359376B2 (en) 2001-11-08 2008-01-10 Elan Pharmaceuticals, Inc. N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate

Also Published As

Publication number Publication date
NO20030182L (no) 2003-01-14
NO330303B1 (no) 2011-03-28
US20050013852A1 (en) 2005-01-20
CZ299086B6 (cs) 2008-04-23
JP2004503591A (ja) 2004-02-05
HUP0301089A2 (hu) 2003-09-29
PL221283B1 (pl) 2016-03-31
DE50101929D1 (de) 2004-05-13
CA2416147C (en) 2008-11-18
DE10034673C1 (de) 2002-04-25
ES2215924T3 (es) 2004-10-16
US7951395B2 (en) 2011-05-31
EP1303267A1 (de) 2003-04-23
HU230272B1 (hu) 2015-11-30
AU2001281980B2 (en) 2006-04-06
RU2262930C2 (ru) 2005-10-27
HUP0301089A3 (en) 2006-07-28
DK1303267T3 (da) 2004-06-14
PT1303267E (pt) 2004-07-30
NO20030182D0 (no) 2003-01-14
AU8198001A (en) 2002-01-30
TR200400865T4 (tr) 2004-06-21
NZ523798A (en) 2005-04-29
ATE263557T1 (de) 2004-04-15
JP4469131B2 (ja) 2010-05-26
WO2002005809A1 (de) 2002-01-24
CZ2003118A3 (cs) 2003-05-14
CA2416147A1 (en) 2002-01-24
ZA200210267B (en) 2003-06-12
EP1303267B1 (de) 2004-04-07

Similar Documents

Publication Publication Date Title
CY1106577T1 (el) Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος
PL365380A1 (pl) Skórny układ aplikacyjny dla kwasu aminolewulinowego
BR0009762A (pt) Catalisador para produção de ácido acético ou ácido acético e acetato de etila, processo para sua produção e processo para produção de ácido acético ou ácido acético e acetato de etila usando-o
ES2184408T3 (es) Sistema transdermico que contiene un antioxidante.
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
ES2182234T3 (es) Inhibidores de metaloproteasa.
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
NO20013675D0 (no) 2,3,4,5-Tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinaseinhibitorer
EE9900180A (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
BR0013515A (pt) Inibidores de sintase de ácido graxo
DE50107209D1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
ATE205822T1 (de) Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
ATE242763T1 (de) Methoximinophenylessigsäureamide
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação
ES2042409A1 (es) Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos.
PT1100821E (pt) Compostos anti-inflammatorios derivados de lipocortina-1
HN1997000029A (es) Acido bifenil butirico y sus derivados como inhibidores de metaloproteinasol de matriz.